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A mouse monoclonal antibody, H3a, directed against 
the newly described epidermolysis bullosa acquisita 
(EBA) antigen was obtained using hybridoma tech-
niques. The distribution of the monoclonal antibody is 
identical to that of the polyclonal serum antibody of 
patients with EBA. By immunofluorescence, a linear 
band is seen at the dermal-epidermal junction and, by 
immunoelectron microscopy, immune reaction products 
are present in the lamina densa and sublamina densa 
regions. Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis followed by Western immunoblot analy-
sis shows that the monoclonal antibody recognizes 290 
and 145 kilodalton proteins present in the immunizing 
junctional extract, identical with the newly discovered 
EBA antigen. This monoclonal antibody should be useful 
in the further isolation and characterization of the EBA 
antigen. 
Epidermolysis bullosa acquisita (EBA) is a subepidermal 
blistering disease characterized by tissue-bound antibodies and 
circulating IgG autoantibodies to a normal component of the 
cutaneous basement membrane zone (BMZ). lmmunoelectron 
microscopic studies have shown that this component is present 
in the lamina densa and sublamina densa regions of the BMZ 
[1-3]. 
In a recent study [4], BMZ proteins were extracted from 
normal human skin, separated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) and reacted in a 
Western blot assay with serum samples from EBA patients. 
lgG antibodies in these sera bound to a major 290 kD protein 
and a minor 145 kD protein, the EBA antigen(s) . Moreover, 
the antibodies in the patients' sera did not recognize any of the 
known matrix molecules in identical Western blot assays with 
purified components. In addition, the EBA antigen migrates 
differently on SDS-PAGE from other known matrix molecules, 
including laminin, fibronectin , collagens type I, IV, and V, the 
bullous pemphigoid antigen, and elastin. 
In this study, we have used a human skin BMZ extract as an 
immunogen to develop a mouse monoclonal antibody directed 
against the EBA antigen. This monoclonal antibody, H3a, 
should be valuable in further isolation and characterization of 
the EBA antigen. 
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MATERIALS AND METHODS 
Preparation of Dermal BMZ Extract 
Whole human skin sections were separated at the level of the lamina 
Iucida by incubation in 1M sodium chloride solution at 4"C for 4 days. 
The dermal extract was subsequently prepared by extraction for 1 h 
with 8 M urea and 0.3 M beta-mercaptoethanol in 0.5 M Tris-hydro-
chloride, pH 8.5, according to the method of Scaletta et al (5] . 
Preparation of the Hybrid Cell Line and the Hybridoma Antibodies 
The H3a hybridoma was produced by convent ional techniques with 
the modifications described by Goldsmith and Briggaman [6]. BALE/ 
c mice (Charles River, Wilmington, Massachusetts) were immunized 
wit h an i.p. injection of 2.5 mg of 1-h BMZ extract in 0.25 ml phosphate-
buffered saline (PBS) homogenized with an equal volume of complete 
Freund's adjuvant. Four weeks later a booster of 1 mg BMZ extract in 
0.5 ml PBS (wit hout adjuvant) was given i.p. , and a final booster of 1 
mg BMZ extract in 0.5 ml PBS was injected 3 days before harvesting 
of the mouse spleen. Nonsecreting P3/NS1 mouse myeloma cells were 
fused with splenic lymphocytes, and grown in HMT medium over STO 
cell feeder layers (HGPRT-negative mouse fibroblast lines). Culture 
supernatants were screened for anti -B MZ antibodies by indirect im-
munofluorescence using neonatal human foreskin as substrate, and 
cultures of interest were cloned by limiting dilution. 
The supernatants of monoclonal cell cultures were collected and 
concentrated by ultrafiltration using an XM50 Amicon membrane 
molecular weight cut-off 50,000 (Amicon Corp., Danvers, Massachu~ 
setts). The antibody was then purified by DEAE Affi-gel Blue cllfo-
matography (Bio-Rad Laboratories, Richmond, California) using a 
Tris-HCI .02 M, pH 7.2 buffer [7]. and 70 mM NaCI to elute the IgG. 
Ant ibody protein concentration was determined by absorbance spec-
trophotometry at OD280, and final ant ibody t iter was ascertained by 
indirect immunofluorescence of serial dilut ions. 
Assays 
Immunofluorescence: Frozen tissues were cut in 8-J.Lm sections and 
air-dried on glass slides. Sections were overlaid with undiluted hybri-
doma culture media, or EBA sera diluted 1:20, incubated in a moist 
chamber at room temperature for 30 min, and t hen washed with PBS. 
The t issue was subsequently treated with fluoresceinated goat anti-
mouse IgG or antihuman IgG (1:20 dilutions, Cappel Laboratories 
Cochranville, Pennsylvania) fo r 30 min and washed with PBS. Th~ 
slides were mounted in 90% glycerol-PBS and examined under a Leitz 
fluorescent microscope. 
Immunoelectron microscopy: Frozen specimens were cut into 10-J.Lm 
sections and air-dried. The t issue was incubated with undiluted H3a 
supernatant or control media for 30 min in a moist chamber at room 
temperature and washed with PBS. The tissue was subsequently treated 
with fluorescein isothiocyanate (FITC)-goat anti mouse IgG diluted 1:20 
in PBS, FITC-rabbit antigoat IgG diluted 1:1 in PBS with 50% normal 
rabbit serum , goat anti-horseradish peroxidase diluted 1:1 in PBS wi th 
50% normal rabbit serum (Cappel Laboratories, Cochranville, Penn-
sylvania) and finally, horseradish peroxidase 1 mg per 20 ml PBS 
(Sigma, St. Louis, Missouri), all steps separated by washing in PBS 
twice. Tissues were subsequently fixed in 2.5% glutaraldehyde, stained 
with Hanker-Yates reagent (Polysciences, Warrington, Pennsylvania) 
in 0.1 M Tris buffer, pH 7.5, with 1% H20 2 and postfixed in 1% osmium 
tetroxide in 0.1 M phosphate buffer. The specimen then was serially 
dehydrated in 50-100% ethanol, embedded in Epon, sectioned with a 
diamond knife, and examined in a JEM 100B electron microscope. 
SDS-PAGE and Western immunoblot analysis: The extracted BMZ 
proteins were separated by SDS-PAGE as described by Laemmli [8] 
under reducing conditions using 5% separating gels and 3% stacking 
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gels. T he separated proteins were electrophoretically transferred from 
t he acrylamide gels to nitrocellulose paper (Western blot) overnight at 
60 rnA using a Hoefer t ransblot apparatus (Hoefer Scientific Instru-
ments, San Francisco, California) [9]. The nitrocellulose sheet was cut 
into strips of one la ne each. A high-molecular-weight lane and a BMZ 
extract lane were stained with 0.1% am ido black. The remaining 
nitrocellulose strips were saturated with 3% bovine serum a lbumin in 
Tris-buffered saline for 1 h, then washed and incubated for 4 h with 
undiluted H3a supernatant, medium, or EBA serum, diluted 1:200. The 
strips were washed 8 times, and subsequently incubated for 3- 4 h with 
1251-labeled affin ity-purified rabbit antimouse IgG F(ab') 2 (for H3a 
supernatant and media) or [125l ]staphylococcal protein A (for EBA 
serum) prepared by the method of Hunter and G ree nwood [10]. Strips 
were washed twice, then overnight, exposed to Kodak X-Omat film for 
up to 72 h at -70"C, and developed. 
The rabbit antiserum to mouse lgG F(ab')2 fragments (Cappel Lab-
oratories, West Chester, Pennsylvania) was purified by precipitation 
at 45 % ammonium sulfate and chromatography on DEAE-cellulose 
[11]. The lgG fraction was af!in ity purified on mouse IgG Sepharose 
which was produced by 45% ammonium sulfate precipitation of mouse 
lgG, purification on DEAE-cellulose [11], and coupling to Sepharose 
48 by the method of Parikh et al [12]. The affinity-purified rabbi t 
antimouse JgG fraction was subsequently eluted with 1.0 M acetic acid 
in to tubes contain ing 1.0 M unbuffered Tris base, and dialyzed. This 
affinity-purified rabbit antimouse lgG F(ab'h was labeled with [1251] 
Nal (Amersham, Arlington Heights, Illinois) to a specific activity of 
4.9 X 104 cpm per ng [10] . The ability of the labe led antibody to detect 
mouse antibody was tested with a monoclonal antibody to epithelial 
cells, and was confirmed by fluorescence studies conducted in parallel. 
Characterization of the Monoclonal Antibody 
Antibody isotypin.g: Standard Ouchterlony double-diffusion tech-
niques were employed for typing the monoclonal antibody using im-
munoglobulin class-specific rabbit antimouse antisera against the fol-
lowing determinants: G1, G2a, G2b, G3, M, A, kappa light chain, and 
lambda light chain (Bionetics, Charleston, South Carolina). 
Complement fixation: Complement fixation was assessed by incuba-
tion of neonatal human foreskin for 30 min with H3a, then with human 
C3 in a moist chamber at 37"C for 45 min. After washing with PBS, 
we added goat antihuman C3 (1:10 dilution, Cappel Laboratories, 
Cochranville, Pennsylvania) for 30 min and washed with PBS. Slides 
were mounted in 90% glycerol-PBS. 
Staphylococcal protein A binding: Tissue treated with H3a was 
overlaid with undiluted nuorescein-conjugated staphylococcal protein 
A for 30 min, washed, and examined. In addition, [125l]staphylococcal 
protein A labeling of H3a-treated nitrocellulose papers with BMZ 
extracts was compared with [125l]rabbit anti mouse labe ling of Western 
immunoblots. 
RESULTS 
Immunofluorescence and lmmunoelectron Microscopic Studies 
Indirect immunofluorescence staining of normal human skin 
with H3a showed a linear band of fluorescence at the dermal-
epidermal junction without staining of vascular BMZ (Fig 1). 
Sections treated with HMT medium rather than H3a were 
FIG 1. Linear deposition of H3a by immunof1uorescence at the BMZ 
of human neonatal foreskin (X 870). 
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FIG 2. Immunoelectron micrograph prepared with H3a antibody 
shows the localization of reaction product (arrow) in and below the 
lamina densa (LD). Lamina Iucida (LL) is free of reaction products. 
Hemidesmosomes (H) were stained equally on both control and anti-
body (H3a)-treated specimens. AF = anchoring fibrils. Uranyl acetate 
and lead citrate. Calibration bar= 1 J.Lffi. 
FIG 3. Immunoelectron micrograph with H3a antibody. An area of 
dermal-epidermal junction is seen in which a basal keratinocyte (K) 
and melanocyte (M) are adjacent, with dermis (D) beneath. Reaction 
products (arrow) are present beneath the keratinocyte but absent under 
the melanocyte. Uranyl acetate and lead citrate. Calibration bar = 1 
J.Lffi . 
devoid of fluorescence. Sections treated with serum samples 
from EBA patients showed a linear pattern of fluorescence 
identical to that seen with H3a, except that the background 
nonspecific fluorescence was much greater when polyclonal 
EBA sera were used. 
Ultrastructural immunoperoxidase staining of normal hu-
man skin incubated with H3a revealed a heavy continuous 
band of electron-dense reaction product localized to the lamina 
densa and immediate sublamina densa regions without prefer-
ential aggregation at sites of anchoring fibrils or hemidesmo-
somes (Fig 2). This pattern was also seen with immunoelectron 
microscopy of tissue sections treated with sera from patients 
with EBA. The band of electron-dense deposition followed the 
contour of the basal keratinocytes but was diminished or absent 
beneath the plasma membrane of melanocytes (Fig 3). 
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FIG 4. Identical binding patterns of H3a and polyclonal EBA serum 
antibodies to 145 and 290 kD proteins of junctional extract by Western 
immunoblot analysis. The left two lanes were treated with H3a antibody 
(H3a), and the third and fourth lanes with sera from 2 different patients 
with EBA (EBA ). 
SDS-PAGE and Western. Jmmunoblot Analysis 
Lanes of the BMZ extract transferred to nitrocellulose paper 
and stained with amido black revealed more than 100 protein 
bands. When identical unstained lanes were incubated with 
H3a antibody, the antibody bound to 2 bands: a major band of 
290 kD and a minor band of 145 kD (Fig 4). These protein 
bands were also bound by antibodies in serum samples from 7 
patients with EBA, but not with serum samples from normal 
individuals or patients with other blistering diseases. H3a did 
not bind in the Western immunoblots to known matrix com-
ponents, including elastin, laminin, fibronectin and collagens 
type I, IV, and V. 
Characterization of the H3a Monoclonal Antibody 
By isotype analysis, the H3a was an lgG" kappa antibody. 
The monoclonal antibody showed no binding to complement 
or staphylococcal protein A. The protein concentration of pur-
ified antibody ranged from 5.7-20 mg/ ml with a limiting dilu-
tion titer of 1:400 to 1:3200. 
DISCUSSION 
In this study, we have described a new monoclonal antibody, 
H3a, which is specifically directed against the EBA antigen. 
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This monoclonal antibody binds to an antigen localized to the 
lamina densa and sublamina densa region, a pattern which 
matches that of polyclonal antibodies from patients with EBA . 
Even more convincing are the data from the Western immu-
noblot experiments in which both H3a and sera from EBA 
patients bound to 290 kD and 145 kD proteins in extracts of 
human skin basement membrane. The monoclonal nature of 
H3a is supported by finding only one immunoglobulin subclass 
(IgG ~> kappa) produced by this hybridoma. 
When compared with immunofluorescent staining using the 
polyclonal EBA serum antibodies, the H3a monoclonal anti-
body stains the dermal -epidermal junction of normal human 
skin with minimal nonspecific background fluorescence . H3a 
promises to be useful in assessing the distribution of the EBA 
antigen in various human and animal tissues, as well as in 
studying its appearance in gestational development and relative 
concentration in different human tissue sites. Finally, the mon-
oclonal antibody in its unlimited supply should be valuable in 
isolating and subsequently further characterizing the EBA an-
tigen itself. 
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